heiBIB: Schreiber, Annette

Schreiber, AnnetteUniversität HeidelbergHeidelberg

Publikationsjahre

Publikationstypen

Sprache

Co-Autoren (Uni Heidelberg)

Proetel, Ulrike: Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients : a subanalysis of the randomized CML-Study IV / Ulrike Proetel, Nadine Pletsch, Michael Lauseker, Martin C. Müller, Benjamin Hanfstein, Stefan W. Kr… , 2014. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 93(2014), 7, Seite 1167-1176
DOI: 10.1007/s00277-014-2041-0
Hehlmann, Rüdiger: Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib : results from the randomized CML-study IV / Hehlmann, Rüdiger; Müller, Martin C.; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schre… , 2014. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 5, Seite 415-423
DOI: 10.1200/JCO.2013.49.9020
Kalmanti, Lida: Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators : results from the randomized CML study IV / Lida Kalmanti, Susanne Saussele, Michael Lauseker, Ulrike Proetel, Martin C. Müller, Benjamin Hanfst… , 2014. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 93(2014), 1, Seite 71-80
DOI: 10.1007/s00277-013-1937-4

GND:	1065689241

Schreiber, Annette in ...

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).